Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Change in Account Payables: 2011-2025

Historic Change in Account Payables for Enanta Pharmaceuticals (ENTA) over the last 15 years, with Sep 2025 value amounting to -$1.3 million.

  • Enanta Pharmaceuticals' Change in Account Payables rose 52.99% to -$723,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 million, marking a year-over-year decrease of 216.67%. This contributed to the annual value of -$1.3 million for FY2025, which is 216.67% down from last year.
  • As of FY2025, Enanta Pharmaceuticals' Change in Account Payables stood at -$1.3 million, which was down 216.67% from -$414,000 recorded in FY2024.
  • Enanta Pharmaceuticals' 5-year Change in Account Payables high stood at $3.8 million for FY2021, and its period low was -$4.6 million during FY2022.
  • Over the past 3 years, Enanta Pharmaceuticals' median Change in Account Payables value was -$1.2 million (recorded in 2023), while the average stood at -$958,667.
  • Per our database at Business Quant, Enanta Pharmaceuticals' Change in Account Payables soared by 527.41% in 2021 and then plummeted by 222.79% in 2022.
  • Yearly analysis of 5 years shows Enanta Pharmaceuticals' Change in Account Payables stood at $3.8 million in 2021, then crashed by 222.79% to -$4.6 million in 2022, then skyrocketed by 75.16% to -$1.2 million in 2023, then skyrocketed by 64.03% to -$414,000 in 2024, then crashed by 216.67% to -$1.3 million in 2025.